Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb 19;9(1):2271.
doi: 10.1038/s41598-018-38295-8.

Assessing Molecular Epidemiology of Carbapenem-resistant Klebsiella pneumoniae (CR-KP) with MLST and MALDI-TOF in Central China

Affiliations

Assessing Molecular Epidemiology of Carbapenem-resistant Klebsiella pneumoniae (CR-KP) with MLST and MALDI-TOF in Central China

Xiujuan Meng et al. Sci Rep. .

Abstract

Carbapenem-resistant K. pneumoniae (CR-KP) posts significant public health challenge worldwide. The aim of this study is to assess clinical characteristics and molecular epidemiology of CR-KP infections with Multilocus sequence typing (MLST) and Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF) in Central China. A total of 71 CR-KP isolates were recovered in a teaching hospital from October 2014 to December 2015. Among all CR-KP isolates, 73.2% (52) produced K. pneumoniae carbapenemases-2 (KPC-2). Eighteen ST types were identified by MLST, among these ST types, forty-seven isolates belonged to ST11 type, which was the predominant outbreak strain in China, and most ST11 isolates produced KPC-2. Eleven mass spectrometry (MS) types were identified by MALDI-TOF MS analysis, 53.5% isolates were MS4 and MS6, which matched with ST11 in MLST analysis. CR-KP infection was associated with increased medical cost and longer hospitalization. Therefore, we found that KPC-2-producing ST11 (MS4 and MS6) CR-KP isolates were the predominant clone identified by MLST and MALDI-TOF, and CR-KP infection was associated with increased hospital costs and longer hospitalization.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
The distribution of carbapenem-resistant K. pneumoniae. The percentage of carbapenem-resistant K. pneumoniae (CR-KP) strains recovered from different wards and different sites are presented in this figure. Categorical variables in the figure are (no., %), ICU = intensive care unit.
Figure 2
Figure 2
Representative spectra of the carbapenem-resistant K. pneumoniae strains. A and B show spectra of two representative strains (the strains marked 1 and 2) in our study, respectively.
Figure 3
Figure 3
Magnified dendrogram (representation of hierarchical cluster analysis) of the carbapenem-resistant K. pneumoniae. ST types, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry types, resistant genes, and infection wards of the carbapenem-resistant K. pneumoniae strains are described.
Figure 4
Figure 4
Monthly distribution of multilocus sequence typing (ST) and mass spectrometry types (MS). A shows the distribution of ST types of multilocus sequence typing, ST11cluster and a peak period for outbreak in May and June 2015. B shows the distribution of mass spectrometry (MS) types, mainly MS6, MS4, and MS8 clusters.

References

    1. Ahmad TA, Haroun M, Hussein AA, El Ashry el SH, El-Sayed LH. Development of a new trend conjugate vaccine for the prevention of Klebsiella pneumoniae. Infectious disease reports. 2012;4:e33. doi: 10.4081/idr.2012.e33. - DOI - PMC - PubMed
    1. Neuhauser MM, et al. Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. Jama. 2003;289:885–888. doi: 10.1001/jama.289.7.885. - DOI - PubMed
    1. Orsi GB, et al. Risk factors and clinical significance of ertapenem-resistant Klebsiella pneumoniae in hospitalised patients. The Journal of hospital infection. 2011;78:54–58. doi: 10.1016/j.jhin.2011.01.014. - DOI - PubMed
    1. Won SY, et al. Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clinical infectious diseases. 2011;53:532–540. doi: 10.1093/cid/cir482. - DOI - PubMed
    1. Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clinical microbiology reviews. 2012;25:682–707. doi: 10.1128/CMR.05035-11. - DOI - PMC - PubMed

Publication types